Analyst ratings can significantly influence the market's perception of a stock. In this case, HC Wainwright & Co.'s reiteration of a 'Buy' rating and a maintained price target for Kiora Pharmaceuticals indicates a positive outlook for the company, which could potentially lead to an increase in the stock's price in the short term.